Waltz Quoted on ROI from Anti-Fraud Efforts Under President Trump

20 March 2017 Bloomberg BNA News

Bloomberg BNA

Partner Judy Waltz was quoted in a Bloomberg BNA article, “Trump Budget Would Boost Spending to Fight Medicare, Medicaid Fraud,” covering the ideal return on investment from anti-fraud efforts, and the integrity of the Trump administration’s anti-fraud program as a whole.

Waltz explains that the support for program integrity “is because the [Health Care Fraud and Abuse Control] program has been able to demonstrate a good return on investment, both in actual dollars and in the nonquantifiable deterrent side as well.”

She continues to say that, however, “with the administration’s statements about reducing regulatory burdens, there may be less emphasis on fraud, waste and abuse allegations that reflect regulatory noncompliance [in the future].”

Insights

Act Now: Employer Obligations Under New York HERO Act
02 August 2021
Labor & Employment Law Perspectives
$15 Minimum Wage for Federal Government Contractors Starting in January 2022
02 August 2021
Labor & Employment Law Perspectives
Supreme Court Limits Patent Assignor Estoppel
02 August 2021
PharmaPatents
Review of Recent Whistleblower Developments
30 July 2021
Legal News: Whistleblower Developments
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream